Last Update:
February 23, 2018
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Videos
| |
|
HIV and hepatitis C survival in used syringes
|
|
Journal Papers,
Abstracts,
and Commentaries
| |
Emergency hybrid approach to ruptured femoral pseudoaneurysm
in HIV-positive intravenous drug abusers.
Domanin M, Romagnoni G, Romagnoli S,
et al
Ann Vasc Surg. 2016 Nov 28.
Abstract
FULL-TEXT
ARTICLE
The Impact of Methadone
Maintenance Treatment on HIV
Risk Behaviors among High-Risk
Injection Drug Users: A
Systematic Review.
Karki P, Shrestha R, Huedo-Medina
TB, Copenhaver M.
Evid
Based Med Public Health.
Apr 7.
2016;
Paper
HIV infection among persons who inject drugs: Ending old
epidemics and addressing new outbreaks.
Des Jarlais DC, Kerr T, Carrieri P, et
al
AIDS. 2016 Feb 1.
Daily alcohol Use as an independent risk factor for HIV
seroconversion among people who inject drugs.
Young S, Wood E, Dong H, et al.
Addiction. 2015 Dec 7.
Abstract
Heroin inhibits HIV-restriction miRNAs and enhances HIV
infection of macrophages.
Wang X, Ma TC, Li JL
Front Microbiol.
2015 Nov 4;6:1230.
Abstract
HIV treatment cascade in MSM, people who inject drugs, and
sex workers.
Risher K, Mayer KH, Beyrer C.
Curr Opin HIV AIDS.
2015 Sep 8.
Abstract
FULL-TEXT ARTICLE
Characterization of HIV-1 envelopes in acutely and chronically infected
injection drug users.
Etemad B, Gonzalez OA, White L, et a
;jRetrovirology.
2014 Nov 28;11(1):106
Paper
Syndemic Vulnerability, Sexual and Injection Risk Behaviors,
and HIV Continuum of Care Outcomes in HIV-Positive Injection Drug Users.
Mizuno Y, Purcell DW, Knowlton AR,
et al
AIDS Behav. 2014 Sep 24
Abstract
Estimation of the Standardized Risk Difference and Ratio in a Competing
Risks Framework: Application to Injection Drug Use
and Progression to AIDS After Initiation of Antiretroviral Therapy.
Cole SR, Lau B, Eron JJ, Brookhart MA,
et al
Am J Epidemiol. 2014 Jun 24.
Abstract
FULL TEXT ARTICLE
Risk Factors
for Vitamin D Deficiency among HIV-Infected and Uninfected Injection Drug
Users.
Lambert AA, Drummond MB, Mehta SH, et al
PLoS One. 2014 Apr
22;9(4):e95802.
Paper
Vitamin-D pathway genes and HIV-1 disease progression in
injection drug users.
Laplana M, Sánchez-de-la-Torre M, Puig T, et al
Gene. 2014 Apr 21.|
Abstract
People Who Inject Drugs in Intimate Relationships: It Takes
Two to Combat HIV.
El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA.
Curr HIV/AIDS Rep. 2014 Jan 30.
Abstract
What has been achieved in HIV prevention, treatment and care
for people who inject drugs, 2010-2012? A review of the six highest burden
countries.
Degenhardt L, Mathers BM, Wirtz AL,
et
al
Int J Drug Policy. 2013 Sep 4.
Abstract
The efficiency of targeted intervention in limiting the spread
of HIV and Hepatitis C Virus among injecting drug users.
De Vos AS, Kretzschmar ME.
J Theor Biol. 2013 May
31.
Abstract
Substance Abuse Treatment, HIV/AIDS, and the Continuum of
Response for People Who Inject Drugs.
Kresina TF, Lubran R, Clark HW, Cheever LW.
Adv Prev Med. 2012;2012:541489.
Abstract
HIV treatment as prevention among injection drug users.
Wood E, Milloy MJ, Montaner JS.
Curr Opin HIV AIDS.
2012 Jan 5
Abstract
Rescue of HIV-1 long-time archived X4 strains to escape
maraviroc.
Baatz F, Struck D, Lemaire M, De Landtsheer S, et al
Antiviral Res. 2011 Dec;92(3):488-92
Abstract
The relationship between injection and noninjection drug use and
HIV disease progression.
Qian HZ, Stinnette SE, Rebeiro PF, et al
J Subst Abuse Treat. 2011 Feb 22.
Abstract |
Does initiation of HIV antiretroviral therapy influence patterns of syringe
lending among injection
drug users?
Kuyper L, Milloy MJ, Marshall BD, et al
Addict Behav. 2011 Jan 21
Abstract
A greater prevalence of X4 viruses in HIV-1 infected intravenous
drug users reflects a "CD4+ effect"
Monno L, Scudeller L, Ladisa N, et al
AIDS Res Hum Retroviruses. 2010 Dec 2
Abstract |
HIV and risk environment for injecting drug users: the past,
present, and future.
Strathdee SA, Hallett TB, Bobrova N, et al
Lancet. 2010 Jul 20.
Abstract |
Treatment and care for injecting drug users with HIV infection: a review of
barriers and
ways forward.
Wolfe D, Carrieri MP, Shepard D.
Lancet. 2010 Jul 20
Abstract |
Learning from HIV epidemics among injecting drug users.
Jarlais DC.
Int J Drug Policy.
2009 Dec 15.
Abstract |
Smoking of crack cocaine as a risk factor for HIV
infection among people who use injection drugs.
Debeck K, Kerr T, Li K, Fischer B, et al
CMAJ. 2009 Oct 19.
Abstract |
Relationship of Injection Drug Use, Antiretroviral Therapy Resistance,
and Genetic Diversity in t
he HIV-1 pol Gene.
Kowalski J, Gange SJ, Schneider MF, et al
J Acquir Immune Defic Syndr.
2009 Feb 12
Abstract
|
Prognostic Factors for Survival Differ According to CD4+ Cell Count
Among HIV-Infected
Injection Drug Users: Pre-HAART and HAART Eras.
Galai N, Vlahov D, Bareta JC,et al
J Acquir Immune Defic Syndr.
2005 Jan 1;38(1):74-81.
Abstract
|
Injection drug use and crack cocaine smoking: independent
and dual risk behaviors f
or HIV infection.
McCoy CB, Lai S, Metsch LR, et al
Ann Epidemiol. 2004 Sep;14(8):535-42.
Abstract
|
HIV-Positive Injection Drug Users Who Leave the Hospital Against Medical
Advice:
The Mitigating Role of Methadone and Social Support.
Chan AC, Palepu A, Guh DP, et al
J Acquir Immune Defic Syndr. 2004 Jan
1;35(1):56-59.
Abstract |
|
General
Reports 
Drug Regimens
